546 related articles for article (PubMed ID: 30731360)
1. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
2. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
Kumar B; Kumar M; Dwivedi AR; Kumar V
ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach.
Mubashir N; Fatima R; Naeem S
Curr Comput Aided Drug Des; 2020; 16(4):420-434. PubMed ID: 32883197
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors.
Li S; Lv X; Cheng K; Tian Y; Huang X; Kong H; Duan Y; Han J; Liao C; Xie Z
Bioorg Med Chem Lett; 2019 May; 29(9):1090-1093. PubMed ID: 30833108
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
Kumar B; Sheetal ; Mantha AK; Kumar V
Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
Tripathi RK; Krishnamurthy S; Ayyannan SR
ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
[TBL] [Abstract][Full Text] [Related]
10. Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B.
Meleddu R; Distinto S; Cirilli R; Alcaro S; Yanez M; Sanna ML; Corona A; Melis C; Bianco G; Matyus P; Cottiglia F; Maccioni E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):264-270. PubMed ID: 28097874
[TBL] [Abstract][Full Text] [Related]
11. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L
Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056
[TBL] [Abstract][Full Text] [Related]
12. Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility.
Yoshimi K; Kozuka M; Sakai J; Iizawa T; Shimizu Y; Kaneko I; Kojima K; Iwata N
Jpn J Pharmacol; 2002 Feb; 88(2):174-82. PubMed ID: 11928718
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
Baek SC; Ryu HW; Kang MG; Lee H; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2018 Aug; 28(14):2403-2407. PubMed ID: 29925480
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
[TBL] [Abstract][Full Text] [Related]
15. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug.
Pflüger P; Pereira P; Loza MI; Brea J; Viña D; Kumar A; Fontenla JA
Eur J Pharmacol; 2021 Sep; 906():174276. PubMed ID: 34174267
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide, a Reversible Monoamine Oxidase Inhibitor.
Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2016; 16(2):112-9. PubMed ID: 26299850
[TBL] [Abstract][Full Text] [Related]
18. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
[TBL] [Abstract][Full Text] [Related]
19. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
